Terbutaline Sulfate NDC 24979-133

NDC codes

FDA NDC Directory

Product NDC (as listed)24979-133Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24979-0133Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24979-133-01	24979013301	100 TABLET in 1 BOTTLE (24979-133-01)Marketed from Jul 13, 2020
24979-133-03	24979013303	1000 TABLET in 1 BOTTLE (24979-133-03)Marketed from Jul 13, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Terbutaline Sulfate
Generic name (nonproprietary): terbutaline sulfate
Active ingredients: Terbutaline sulfate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211832
Marketing start: Jul 13, 2020
Listing expires: Dec 31, 2026
Identifiers: Product ID 24979-133_3fd94b35-ef5a-4eb3-a3bd-0ce7572521d6SPL ID 3fd94b35-ef5a-4eb3-a3bd-0ce7572521d6SPL set ID 3a4e5046-293c-4616-8679-6da65f31626bRxCUI 857677, 857683UNII 576PU70Y8EUPC 0324979133010, 0324979132013

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424979013301 followed by a unit qualifier and the quantity

Package 24979-0133-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 27, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211832

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211832
Product	Strength	Form · route	Labeler	Product NDC
Terbutaline Sulfate	Terbutaline sulfate 2.5 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	24979-132
Terbutaline Sulfate	Terbutaline sulfate 2.5 mg/1	TabletOral	Proficient Rx LP	71205-938
Terbutaline Sulfate	Terbutaline sulfate 5 mg/1	TabletOral	Proficient Rx LP	71205-939